The process is straightforward, though expert medical supervision throughout is essential
Sleep apnea improvement: ZepBound is now FDA-approved for sleep apnea in people with obesity, as weight loss can ease symptoms like snoring and disrupted breathing
For many individuals, starting with a simple foundation such as a multivitamin, protein support, and electrolytes is often enough to create a strong routine
Canadian Access and Coverage Considerations Canadian patients face unique considerations when evaluating these medications
When supplements that also lower blood sugar or affect gastrointestinal motility are added to the mix, the combined effects may become excessive
Cochrane-standard systematic reviews have examined the randomized controlled trial data across multiple GLP-1 medications, and the weight of the published evidence supports the conclusion that in properly selected patients, GLP-1 receptor agonists produce clinically meaningful weight loss that exceeds what diet and exercise alone typically achieve without pharmacological support
